T-cell receptor gene transfer by lentiviral vectors in adoptive cell therapy (Q36842738)

16 August 2017

1 reference

title

T-cell receptor gene transfer by lentiviral vectors in adoptive cell therapy (English)

1 reference

16 August 2017

Sara Bobisse

1

1 reference

16 August 2017

Paola Zanovello

series ordinal

2

1 reference

16 August 2017

Antonio Rosato

series ordinal

3

1 reference

16 August 2017

language of work or name

English

0 references

publication date

1 June 2007

1 reference

Expert Opinion on Biological Therapy

16 August 2017

published in

1 reference

16 August 2017

volume

7

1 reference

16 August 2017

issue

6

1 reference

16 August 2017

page(s)

893-906

1 reference

Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

CD8+ cytotoxic T cell therapy of cytomegalovirus and HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Cancer immunotherapy: moving beyond current vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Adoptive transfer of vaccine-induced peripheral blood mononuclear cells to patients with metastatic melanoma following lymphodepletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Sinks, suppressors and antigen presenters: how lymphodepletion enhances T cell-mediated tumor immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Cutting edge: persistence of transferred lymphocyte clonotypes correlates with cancer regression in patients receiving cell transfer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Cancer regression in patients with metastatic melanoma after the transfer of autologous antitumor lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Transfer of specificity by murine alpha and beta T-cell receptor genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Gene therapy in peripheral blood lymphocytes and bone marrow for ADA- immunodeficient patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Principles for adoptive T cell therapy of human viral diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Targeting tumours with genetically enhanced T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Transfer of the HSV-tk gene into donor peripheral blood lymphocytes for in vivo modulation of donor anti-tumor immunity after allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

T-cell-receptor gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Cancer regression in patients after transfer of genetically engineered lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

High efficiency TCR gene transfer into primary human lymphocytes affords avid recognition of melanoma tumor antigen glycoprotein 100 and does not alter the recognition of autologous melanoma antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Retroviral transduction of a T cell receptor specific for an Epstein-Barr virus-encoded peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Simultaneous generation of CD8+ and CD4+ melanoma-reactive T cells by retroviral-mediated transfer of a single T-cell receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Generation of tumor-specific, HLA class I-restricted human Th1 and Tc1 cells by cell engineering with tumor peptide-specific T-cell receptor genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Primary human lymphocytes transduced with NY-ESO-1 antigen-specific TCR genes recognize and kill diverse human tumor cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Functional reconstitution of class II MHC-restricted T cell immunity mediated by retroviral transfer of the alpha beta TCR complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Peptide fine specificity of anti-glycoprotein 100 CTL is preserved following transfer of engineered TCR alpha beta genes into primary human T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Reprogramming of virus-specific T cells into leukemia-reactive T cells using T cell receptor gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Potentiation of tumor eradication by adoptive immunotherapy with T-cell receptor gene-transduced T-helper type 1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Reconstitution of CD8+ T cells by retroviral transfer of the TCR alpha beta-chain genes isolated from a clonally expanded P815-infiltrating lymphocyte.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Recognition of fresh human tumor by human peripheral blood lymphocytes transduced with a bicistronic retroviral vector encoding a murine anti-p53 TCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Directed evolution of human T-cell receptors with picomolar affinities by phage display.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Redirecting T lymphocyte specificity by T cell receptor gene transfer--a new era for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Targeting lentiviral vector expression to hepatocytes limits transgene-specific immune response and establishes long-term expression of human antihemophilic factor IX in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Highly efficient lentiviral vector-mediated transduction of nondividing, fully reimplantable primary hepatocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Lentivirus-mediated gene transfer in primary T cells is enhanced by a central DNA flap.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Distinct genomic integration of MLV and SIV vectors in primate hematopoietic stem and progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Retroviral vector integration occurs in preferred genomic targets of human bone marrow-repopulating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

HIV-1 integration in the human genome favors active genes and local hotspots

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

RNA 3' readthrough of oncoretrovirus and lentivirus: implications for vector safety and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Safe two-plasmid production for the first clinical lentivirus vector that achieves >99% transduction in primary cells using a one-step protocol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Efficient lentiviral vector-mediated control of HIV-1 replication in CD4 lymphocytes from diverse HIV+ infected patients grouped according to CD4 count and viral load

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Gene transfer in humans using a conditionally replicating lentiviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Cytokine-driven proliferation and differentiation of human naive, central memory, and effector memory CD4(+) T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Retrovirus-mediated gene transfer in primary T lymphocytes: influence of the transduction/selection process and of ex vivo expansion on the T cell receptor beta chain hypervariable region repertoire

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Retrovirus-mediated gene transfer in primary T lymphocytes impairs their anti-Epstein-Barr virus potential through both culture-dependent and selection process-dependent mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Adoptive immunotherapy for cancer: building on success

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Progressive differentiation and selection of the fittest in the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

In vivo alloreactive potential of ex vivo-expanded primary T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Immunologic potential of donor lymphocytes expressing a suicide gene for early immune reconstitution after hematopoietic T-cell-depleted stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

High levels of transgene expression following transduction of long-term NOD/SCID-repopulating human cells with a modified lentiviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Gene transfer into stimulated and unstimulated T lymphocytes by HIV-1-derived lentiviral vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Lentivirus-mediated gene transfer and expression in established human tumor antigen-specific cytotoxic T cells and primary unstimulated T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Transcriptional targeting of lentiviral vectors by long terminal repeat enhancer replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Robust and efficient regulation of transgene expression in vivo by improved tetracycline-dependent lentiviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Gene therapy for adenosine deaminase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

High transdominant RevM10 protein levels are required to inhibit HIV-1 replication in cell lines and primary T cells: implication for gene therapy of AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Lentiviral vector-mediated gene transfer in T cells from Wiskott-Aldrich syndrome patients leads to functional correction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Human T lymphocytes transduced by lentiviral vectors in the absence of TCR activation maintain an intact immune competence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Coordinate dual-gene transgenesis by lentiviral vectors carrying synthetic bidirectional promoters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Potential use of T cell receptor genes to modify hematopoietic stem cells for the gene therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Transgenesis by lentiviral vectors: lack of gene silencing in mammalian embryonic stem cells and preimplantation embryos

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors--design, biosafety, and production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Adoptive therapy with CD8(+) T cells: it may get by with a little help from its friends

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Requirement for CD4 T Cell Help in Generating Functional CD8 T Cell Memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Cutting edge: CD4+ T cell control of CD8+ T cell reactivity to a model tumor antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

A phase I study of nonmyeloablative chemotherapy and adoptive transfer of autologous tumor antigen-specific T lymphocytes in patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Immunization of patients with metastatic melanoma using both class I- and class II-restricted peptides from melanoma-associated antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Codon modification of T cell receptors allows enhanced functional expression in transgenic human T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Adoptive immunotherapy for posttransplantation viral infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Alphabeta T-cell receptor engineered gammadelta T cells mediate effective antileukemic reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

Universal tumor antigens as targets for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.893

21 January 2018

Identifiers

DOI

10.1517/14712598.7.6.893

1 reference

16 August 2017

1 reference